MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
Please note: All sites must have greenlight status for protocol 19 before they can activate to protocol 21. Please contact the STAMPEDE team if you require assistance with protocol 19 activation.
Please refer to the essential documents page for all current documents.
To book protocol training dates please refer to the Upcoming Training page (password required).
If you were unable to attend the live sessions, please refer to the site staff protocol 21 training video, found on our Training Materials & Resources page with further information.
To view the training presentation please refer to the Upcoming Training page (password required).
Note: For IBs/SPCs submitted, please go to the reference safety information page.
Note: Metabolic sub-study PIS will only be provided to sites participating in the sub-study.
STAMPEDE
MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
STAMPEDE
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy
See the latest News in STAMPEDE through the link to the right.